The goal of this course series is to provide pharmaceutical scientists with an in-depth understanding of the mechanisms of drug interactions, providing the basis for scientifically justified and clinically sound decisions to prevent or minimize drug interactions.
In this 5-session course, we will explore clinically significant pharmacokinetic drug-drug interactions (DDIs) observed with recently FDA approved drug therapies. The possible mechanisms (e.g., inhibition or induction of metabolizing enzymes and/or transporters, changes in drug absorption, pharmacogenetics, organ impairment) will be reviewed and potential clinical outcomes explained. Mitigation strategies to prevent or minimize the risk of DDIs will be discussed.
Jointly provided by:
- University of Washington (UW) Drug Interaction Solutions, Department of Pharmaceutics
- University of Wisconsin-Madison School of Pharmacy, Division of Pharmacy Professional Development